04/11/2025 12:43 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025 6:45 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025 10:17 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025 9:48 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025 8:43 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2025 7:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 8:54 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/03/2025 11:29 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 9:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2025 12:58 PM | Charmquark TWEE (Filed by) ImmunoPrecise Antibodies (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025 9:30 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for IPA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.
|
01/17/2025 10:30 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/03/2025 9:20 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/23/2024 8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024 7:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024 7:37 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F/A | |
12/10/2024 7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024 7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 8:17 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 7:54 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 6:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024 8:08 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024 2:25 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024 8:39 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 8:13 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 1:40 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 8:04 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024 8:41 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024 7:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 8:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2024 11:15 PM | ImmunoPrecise Antibodies (Filer)
| Form EFFECT | |
08/06/2024 4:16 PM | ImmunoPrecise Antibodies (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
07/30/2024 12:57 PM | ImmunoPrecise Antibodies (Filer)
| Form D Notice of Exempt Offering of Securities | |
07/29/2024 7:35 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024 7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
07/23/2024 8:55 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2024 8:41 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 7:32 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad) A Historic Gold Announcement Is About to Rock Wall Street
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Be ready before the historic gold move. Get Garrett’s Top Four picks now. |
06/25/2024 8:12 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024 12:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024 1:23 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |